Acutaas Chemicals Ltd

Acutaas Chemicals, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting evolving market dynamics. Recent assessment changes highlight a transition in technical indicators, suggesting a nuanced outlook for the stock amid broader market movements.

Acutaas Chemicals, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a bullish to a mildly bullish trend, underscoring the evolving market dynamics for this stock.

Acutaas Chemical has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that highlight the company’s ongoing financial momentum and market positioning within the Pharmaceuticals & Biotechnology sector.

Acutaas Chemicals has reached a significant milestone by touching a new 52-week high of Rs.1901.35, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. This achievement underscores the stock’s strong performance relative to its peers and the broader market.

Acutaas Chemicals has reached a significant milestone by touching a new 52-week high of Rs 1901.35 today, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector amid a mixed market environment.

Acutaas Chemicals has reached a new all-time high, marking a significant milestone in its market journey. The stock's recent surge reflects robust financial metrics and sustained growth within the Pharmaceuticals & Biotechnology sector, underscoring the company’s strong positioning in a competitive industry.

Acutaas Chemicals demonstrated a strong intraday performance on 24 Nov 2025, touching a high of ₹1,826.20, marking a 7.38% rise within the trading session. This surge outpaced the Pharmaceuticals & Biotechnology sector by 8.27%, reflecting notable trading activity and momentum in the stock.

Acutaas Chemicals has achieved a new 52-week high, reflecting strong performance in the small-cap pharmaceuticals and biotechnology sector. The stock has consistently risen over the past four days and is trading above key moving averages, supported by solid financial health and significant net profit growth.

Acutaas Chemicals has achieved a new 52-week high, reflecting strong momentum with significant gains over the past four days. The stock has outperformed its sector and demonstrated high volatility, indicating active trading. It has also delivered impressive returns over the past year, significantly surpassing broader market performance.

Acutaas Chemicals has achieved an all-time high stock price, reflecting strong performance in the pharmaceutical and biotechnology sector. The company has seen significant gains recently, with impressive annual growth in net sales and a low debt-to-equity ratio, indicating robust financial health and investor confidence.

Acutaas Chemicals has achieved a new 52-week high of Rs 1728.4, reflecting a strong performance with a 109.19% return over the past year. The company reported significant growth in net sales and profits, alongside a low debt-to-equity ratio, highlighting its solid financial health and market appeal.

Acutaas Chemicals has achieved a new 52-week high of Rs 1728.4, reflecting significant growth in its stock performance over the past year. The company has consistently outperformed key moving averages and reported strong financial health, including a low debt-to-equity ratio and positive net profit growth for five consecutive quarters.